|
Market Closed -
Canadian Securities Exchange
02:56:32 2026-09-04 pm EDT
|
5-day change | 1st Jan Change | ||
| 0.6300 CAD | +3.28% |
|
+1.61% | -10.00% |
| Aug. 21 | Grown Rogue Shares up 13%, Says Forming Subsidiary to Acquire Cannabis Assets in New York | MT |
| Aug. 05 | Earnings Flash (GRIN.CN) Grown Rogue International Reports Q2 Revenue $11.3M | MT |
| Market Cap | 114M 97.88M 92.06M 84.03M 157M 10.76B 158M 1.09B 422M 5.51B 427M 418M 17.56B | P/E 2024 |
-12x | P/E 2025 | 71.9x |
|---|---|---|---|---|---|
| Enterprise Value | 129M 111M 104M 95.33M 178M 12.21B 179M 1.24B 479M 6.25B 485M 474M 19.92B | EV / Sales 2024 |
5.45x | EV / Sales 2025 | 4.4x |
| Free-Float |
61.86% | Yield 2024 * |
-
| Yield 2025 | - |
Canadian Securities ExchangeCAD
| Markets | Quality | ||
|---|---|---|---|
Canadian Securities Exchange
| GRIN | Delayed | |
OTC Markets
| GRUSF | Delayed | |
|
Deutsche Boerse AG
| 1VF0 | Delayed |
Last Transcript : Grown Rogue International Inc.
| 1 day | +3.28% | ||
| 1 week | +1.61% | ||
| Current month | +1.61% | ||
| 1 month | +5.00% | ||
| 3 months | +3.28% | ||
| 6 months | +40.00% | ||
| Current year | -10.00% |
| 1 week | 0.59 |  | 0.63 |
| 1 month | 0.59 | | 0.69 |
| Current year | 0.38 | | 0.72 |
| 1 year | 0.38 | | 0.72 |
| 3 years | 0.28 | | 1.15 |
| 5 years | 0.06 | | 1.15 |
| 10 years | 0.06 | | 1.15 |
| Manager | Title | Age | Since |
|---|---|---|---|
J. Strickler
CEO | Chief Executive Officer | 45 | 2018-11-14 |
Sarah Strickler
PRN | Corporate Officer/Principal | - | 2016-09-30 |
| Director of Finance/CFO | 42 | 2024-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Stephen Gledhill
BRD | Director/Board Member | 64 | 2018-11-14 |
J. Strickler
BRD | Director/Board Member | 45 | 2018-11-14 |
Ryan Kee
BRD | Director/Board Member | 42 | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 7/21/26 | Option | Director | 120,000 | 0.0480% | ||
| 7/21/26 | Option | Director | 120,000 | 0.0480% | ||
| 7/21/26 | Free | Founder | 1,000,000 | 0.4001% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.28% | +1.61% | +6.78% | +121.05% | 114M | |
| -0.88% | +0.36% | -14.72% | -4.40% | 13.44B | |
| +0.12% | +1.17% | -31.12% | -55.80% | 4.94B | |
| -2.66% | -0.69% | -3.88% | -2.96% | 4.49B | |
| -0.69% | -1.07% | -3.84% | -29.07% | 3.92B | |
| -1.31% | -1.53% | -22.70% | +5.37% | 3.53B | |
| 0.00% | -0.54% | +0.08% | +1.22% | 3.53B | |
| -0.75% | -0.41% | -10.85% | +8.46% | 3.25B | |
| -0.27% | -0.74% | -22.54% | -14.29% | 2.33B | |
| +0.05% | -1.14% | -27.60% | -15.10% | 1.68B | |
| Average | -0.31% | -0.78% | -13.04% | +1.45% | 4.12B | |
| Weighted average by Cap. | -0.80% | -0.59% | -14.49% | -11.06% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 27.02M 23.23M 21.85M 19.95M 37.31M 2.56B 37.43M 259M 100M 1.31B 101M 99.24M 4.17B | 32.43M 27.89M 26.23M 23.94M 44.78M 3.07B 44.93M 311M 120M 1.57B 122M 119M 5B |
| Net income | -11.3M -9.72M -9.14M -8.35M -15.61M -1.07B -15.66M -108M -41.9M -547M -42.45M -41.52M -1.74B | 1.73M 1.49M 1.4M 1.28M 2.39M 164M 2.4M 16.59M 6.41M 83.78M 6.5M 6.35M 267M |
| Net Debt | 3.7M 3.19M 3M 2.74M 5.12M 350M 5.13M 35.53M 13.73M 179M 13.91M 13.61M 571M | 15.3M 13.16M 12.38M 11.3M 21.13M 1.45B 21.2M 147M 56.72M 741M 57.46M 56.2M 2.36B |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-04 | CA$0.6300 | +3.28% | 7,500 |
| 26-09-03 | CA$0.6100 | -1.61% | 5,000 |
| 26-09-02 | CA$0.6200 | 0.00% | 28,500 |
| 26-09-01 | CA$0.6200 | 0.00% | 7,000 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- GRIN Stock
Select your edition
All financial news and data tailored to specific country editions
